Issue 21 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

31

No.

21

May 27, 2005May 27, 2005

Free

DOWNLOAD THE PDF

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

Breast cancer session was ASCO equivalent of a rock concert, discussant says.

Avastin doubles progression-free survival in metastatic disease.

Also MQSA should require mammography facilities to gather data on interpretation, cancer policy board committee says.

Colorado universities install huge NMR magnet. NCI to transfer 5 A Day to CDC.

Recent Issues

Volume 50 | Issue 44 - November 22, 2024

Volume 50 | Issue 43 - November 15, 2024

Volume 50 | Issue 42 - November 08, 2024

Volume 50 | Issue 41 - November 01, 2024

Volume 50 | Issue 40 - October 25, 2024

Volume 50 | Issue 39 - October 18, 2024